All sponsors

Pharming Technologies B.V.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-32
RECRUITING2
READOUTS ≤12 MONTHS2
Open Pharming Technologies B.V. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Leniolisib
NCT05438407
P3Active, not recruitingAPDS152026-11-30 (+30 mo)
FALCON
NCT05650229
P2RecruitingPrimary Mitochondrial Disease1802027-10 (+24 mo)
Leniolisib
NCT05693129
P3Active, not recruitingAPDS162028-07-09 (+42 mo)
Falcon-OLE
NCT07514338
P2RecruitingMitochondrial Diseases1402029-03-31
Leniolisib
NCT06990529
P2Active, not recruitingPIDs Linked to PI3K122029-08-12 (+11 mo)